Lexaria Bioscience (LEXX) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Lexaria Bioscience’s DehydraTECH technology has shown promising results in a 12-week diabetes animal study by outperforming the Rybelsus® control group in body weight and blood sugar control. The DehydraTECH-liraglutide and DehydraTECH-CBD formulations were particularly effective, highlighting the potential of this innovative drug delivery platform.
For further insights into LEXX stock, check out TipRanks’ Stock Analysis page.
